Online Trading India- Simple

The development and shift towards online trading has helped many people to trade successfully. Online trading is beneficial in many ways, as it becomes very easy to trade online. Also because

One only needs a computer, internet connection and knowledge to trade.

Online trading India would only give good returns if done the way it is to be done. Many people invest in shares without having the correct knowledge to trade. Investing in shares involves a lot of knowledge and understanding of the market. As share market is a very unstable market. The Sensex of the share market changes every day, depending on the performance of each company. One should take advantage of the changing market to get best profits.

Trading online offers a number of advantages for the serious investor:

· You can trade from home, or as we saw earlier, from just about anywhere in the world, with an internet connection.

· You can trade more or less any time depending on your knowledge.

· You can become your own boss, work your own hours instead of someone else’s.

· You could make more money in a day than most people make in a month, but having a right investment guide becomes very important.

Your long term and short term goals of trading should be clearly set, as they will help your financial investor to guide you accordingly in the process of selecting shares. Taking financial help from an experienced firm will also help one to avoid wrong decisions. As the share market is very uncertain, with the help of a proper guide one can take advantage of the market and earn more profits.

Online trader charges a very small amount of brokerage, they will guide you on the market status, when to buy and sell shares depending on the returns that you expect. A good online trading India will send you emails on regular intervals to keep you updated on the opportunities related to your portfolio.

So select an experienced firm to help you in Online trading India.

MEDICAL TRANSCRIPTION OUTSOURCING - MYTHS AND MISCONCEPTIONS

What is the deal with us people? We like a brand, we develop high predefined expectations on it and then a smallest of all fall outs converts that admiration into abomination. How does an irrelevant factor (most of the times external) affect your preference?

The very same thing happened with one of my friends. I have been working as a marketing executive for this medical institute in Brooklyn for more than twenty years now. I have seen and been there in the market and it hurts me to see how really naïve we all have become.

It was an age old belief that medical help outsourced to Asian countries never meets up to its expectations and the sum paid. It saddens me to see that this still is existent. A few days back I happened to read this article about how medical help outsourced to India is not worth the single penny and a big mistake.

I would honestly love to ask on what basis are we accusing these medical institutes. Just because one company could not deliver does not speak up for the others. This is unacceptable.

Throughout my career, I have dealt in with many medical institutes. Yes, there are many frauds in the market, but they do not speak up for the entire medical community in India. I have done business with them and I refuse to accept such allegations.

Take Acroseas for an example, the institute has been in the market for a while now, and I would like to say that they are the best. Professionalism- A+, Pragmatism-A+, and most important of all, THEIR SERVICES ARE GENUINE and worth all the money.

We honestly need to grow up, and start seeing things in a very positive manner. Acroseas are the best in the market, they are highly recommended for those looking out for medical outsourcing.

WellPoint’s HealthyChat.com Answers All Your Health-Overhaul Questions

By Avery Johnson

WellPoint’s Anthem unit has launched an online community to answer questions about health reform. Here is the website, which Anthem says is the first of its kind.

The idea behind HealthyChat.com is to provide a forum where people can ask questions about the new federal health-care overhaul bill and their health coverage more broadly. Anyone can log on and post a question, not just Anthem policyholders. Anthem says the site has gotten about 60,000 pageviews since it launched May 1.

The questions being asked are things such as, “I have a child under the age of 26. When can I add her to my policy?” Anthem moderators, whose areas of expertise range from public policy to nursing, post answers to the questions, a spokesman says. The company decided to launch the forum after being inundated with questions following the new law’s March passage, he says.

On one of the forums, Anthem was asked why one policyholder’s premiums went up 31%. The company has been under fire from the Obama administration and state regulators for rate increases, which critics say are the result of industry profits and the industry contends are caused by rising medical costs.

WellPoint used the forum to reiterate the industry’s message, saying: “By law, premiums must reflect the anticipated medical costs of health plans’ members — which means rising health care costs do make a difference when it comes to premiums.” The moderator then ticked off the drivers of health costs, including an aging population and medical inflation.

What Does the Gulf Coast Oil Spill Mean for Human Health?

The ecological implications of the Gulf Coast oil spill may take years to tease out — in fact, it may not ever be possible to fully gauge the extent of the damage, the WSJ reports.

The impact on human health is also a question mark, the Washington Post writes. Initial concerns are focusing on cleanup workers, some of whom were hospitalized this week after reporting nausea, dizziness and headaches. Exposure to the oil, the chemicals being used to disperse it or the combination of the two might produce acute symptoms including the ones the workers reported. However, so might working in hot and humid conditions for hours at a time, the WP notes.

Workers aren’t wearing respirators and hazmat suits because most aren’t being exposed to high levels of fumes, and the weather conditions would make that getup itself potentially hazardous. But workers are supposed to be wearing other protective gear, and the WP says there are reports of some going without even basic protection.

Here’s what a senior scientist from the National Resources Defense Council said earlier this month about the research on health problems among cleanup workers and others involved in previous oil spills. She wrote:

“These studies show that workers and local residents can suffer from health effects after oil spills. The main symptoms are acute headaches, dizziness, skin rashes, irritation of the eyes and throat, and breathing problems. Genetic abnormalities (which are potentially repairable) were also found in some studies but not others. One study reported mental health effects in local residents. These are the health issues we should be watching out for - and protecting against - in the Gulf Coast during the current oil disaster.”

And here’s the EPA’s home page for oil spill information, including air and water quality test results.

Health-Care Overhaul and Industry Outlook: Allergan Little Affected

With its stable of aesthetic products, Allergan won’t be nearly as affected by health-care overhaul as other drug makers and medical product companies. The maker of Botox actuallyboosted its 2010 earnings forecast today, although it did project a $12 million sales hit this year and as much as $70 million in 2011, largely because of greater Medicaid discounts.

The legislative changes being implemented this year — including those Medicaid rebates, the taxation of retiree drug subsidies and a discount on brand name drugs for Medicare Part D participants marooned in the doughnut hole — have a generally negative impact on pharma and biotech companies. Starting in 2014, provisions that will expand coverage to the previously uninsured will have a more positive effect.

Here’s what else we know so far about the impact of health care legislation:

• Bristol-Myers lowered its 2010 earnings estimate by 12 cents a share, to between $1.84 and $1.94 a share, and lowered sales estimates by between $300 million and $400 million, citing the overhaul as one factor. It said the hit to sales and earnings in 2011 will be “double” what it is this year.
• Celgene raised its 2010 sales and earnings estimates, but said changes under the new law would pare about $35 million to $40 million from this year’s sales and as much as $90 million from sales next year. Over the long haul the new law will have only a “modest” impact.
• Merck said sales will be trimmed by about $170 million this year and between $300 million and $350 million in 2011 due to provisions such as Medicaid drug rebates.
• Baxter reduced its 2010 earnings estimate, mostly due to a slowing market for its plasma-based products, but partly due to health-care legislation. It cut its earnings estimate by 28 cents, 10 cents of which it attributed to Medicaid drug rebates.
• Amgen is projecting 2010 sales will be reduced by between $200 million and $250 million.
• Abbott cut its 2010 earnings outlook to a range of $4.13 to $4.18 a share from its earlier outlook of $4.20 to $4.25 a share. Revenue will be down an estimated $230 million in 2010 and an incremental $200 million in 2011.
• Gilead lowered its 2010 net product sales projection to a range of $7.4 billion to $7.5 billion, down from its previous $7.6 billion to $7.7 billion estimate.
• Johnson & Johnson sees 2010 earnings reduced by a nickel, to a range of $4.80 to $4.90 a share excluding certain costs. Health-care legislation will also pare revenue by between $400 million and $500 million.
• Lilly cut its 2010 earnings estimate to a range of $4.35 to $4.50 a share from a previous estimate of $4.65 to $4.85 a share. The company also said its 2010 sales will be clipped by between $350 million and $400 million, and its 2011 sales by as much as $700 million.

Is the Tanning Tax Half Baked?

The horse-trading that helped win doctors’ support for the health-care overhaul included replacing a proposed 5% tax on Botox treatments and elective cosmetic procedures with a 10% tax on indoor tanning services.

The tanning tax made it into the final law and is supposed to raise $2.7 billion over 10 years. The tanning industry’s trade group has been saying anyone who thinks the revenue target is realistic has been standing out in the sun too long. “It’s almost laughable,” the head of the Indoor Tanning Association told the WSJ in December.

An article in the Hill today walks through the math in more detail, using the association’s estimate that there are about 25,000 tanning-bed salons, including some gyms and nail salons, that would be subject to the tax. On that basis, each tanning business would have to collect $108,000 in taxes over the decade to get to the $2.7 billion revenue estimate, the group says.

Some 30 million Americans currently visit tanning salons at least once a year, according to the group. Based on an estimated cost of $7 per session, those customers would have to make about 3.9 billion visits over the decade to hit the tax target.

The Joint Committee on Taxation, which came up with the $2.7 billion figure, told the Hill it couldn’t divulge the economic models it used for the revenue estimate.

Dermatologists and other backers of the tanning tax, which doesn’t apply to sessions done for medical reasons, say it’s a good idea because it will discourage people from being exposed to added cancer risk.

Correction: This post originally said each tanning business would have to collect $108 million in taxes over the decade to get to the $2.7 billion revenue estimate.